Active Ingredient(s): Dasiglucagon Hydrochloride
FDA Approved: * March 22, 2021
Pharm Company: * ZEALAND PHARMA
Category: Diabetes

Dasiglucagon, sold under the brand name Zegalogue, is a medication used to treat severe hypoglycemia in people with diabetes.[1][2] The most common side effects include nausea, vomiting, headache, diarrhea, and injection site pain.[1] Dasiglucagon was approved for medical use in the United States in March 2021.[1][3][4][5] It was designated an orphan drug in August 2017.[6&a... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.